Drug interactions
Ipratropium-salbutamol + Potassium acid
Severity: Minor
Ipratropium-salbutamol and Potassium acid: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Salbutamol can lower serum potassium by driving potassium into cells, while potassium phosphate supplements raise it. The effects oppose each other, so the net change is unpredictable and is mostly relevant at high salbutamol doses or in patients with potassium disturbances.
What this interaction means in plain words
Ipratropium-salbutamol and Potassium acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Beta-2 agonist stimulation of Na+/K+-ATPase shifts potassium intracellularly, pharmacodynamically opposing the potassium load from the supplement.
What to do
Check serum potassium when high-dose or repeated salbutamol is given to patients receiving potassium supplements, especially with renal impairment. Adjust the supplement dose according to results.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Potassium acid, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Frequently asked questions
Can I take Ipratropium-salbutamol with Potassium acid?
MediHelp rates the interaction as minor. Ipratropium-salbutamol and Potassium acid have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Salbutamol can lower serum potassium by driving potassium into cells, while potassium phosphate supplements raise it. The effects oppose each other, so the net change is unpredictable and is mostly relevant at high salbutamol doses or in patients with potassium disturbances.
How serious is the interaction between Ipratropium-salbutamol and Potassium acid?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check serum potassium when high-dose or repeated salbutamol is given to patients receiving potassium supplements, especially with renal impairment. Adjust the supplement dose according to results.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
